We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$257M
AUM Growth
+$20.3M
Cap. Flow
-$3.38M
Cap. Flow %
-1.32%
Top 10 Hldgs %
33.42%
Holding
167
New
24
Increased
41
Reduced
51
Closed
33

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.37M
2
ULTA icon
Ulta Beauty
ULTA
+$2.18M
3
COP icon
ConocoPhillips
COP
+$2.04M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.97M
5
EMR icon
Emerson Electric
EMR
+$1.81M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$4.77M
2
UBER icon
Uber
UBER
+$3.19M
3
PANW icon
Palo Alto Networks
PANW
+$2.27M
4
CRWD icon
CrowdStrike
CRWD
+$2.23M
5
DHI icon
D.R. Horton
DHI
+$2.13M

Sector Composition

Rank Sector Weight
1 Industrials 24.01%
2 Healthcare 17.6%
3 Financials 14.71%
4 Technology 12.6%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRT icon
26
Vertiv
VRT
$93B
$2.79M 1.09%
8,330
+3,380
+68% +$1.07M
SYY icon
27
Sysco
SYY
$40.8B
$2.67M 1.04%
31,954
+7,250
+29% +$549K
KO icon
28
Coca-Cola
KO
$377B
$2.67M 1.04%
32,796
-512
-2% -$40.4K
GILD icon
29
Gilead Sciences
GILD
$162B
$2.66M 1.04%
21,070
+10,000
+90% +$1.32M
EMR icon
30
Emerson Electric
EMR
$83.9B
$2.49M 0.97%
17,388
+12,880
+286% +$1.81M
CB icon
31
Chubb
CB
$135B
$2.44M 0.95%
7,150
+690
+11% +$225K
TFC icon
32
Truist Financial
TFC
$63.3B
$2.43M 0.95%
48,790
+123
+0.3% +$6.05K
NEE icon
33
NextEra Energy
NEE
$181B
$2.25M 0.87%
25,611
+40
+0.2% +$3.62K
REGN icon
34
Regeneron Pharmaceuticals
REGN
$78.5B
$2.17M 0.84%
3,475
+2,900
+504% +$1.97M
KMB icon
35
Kimberly-Clark
KMB
$36.3B
$2.16M 0.84%
19,688
-2,009
-9% -$199K
PG icon
36
Procter & Gamble
PG
$336B
$2.09M 0.81%
14,221
-600
-4% -$87.3K
JPM icon
37
JPMorgan Chase
JPM
$935B
$2.05M 0.8%
6,251
-725
-10% -$225K
SYK icon
38
Stryker
SYK
$125B
$2.03M 0.79%
6,455
+1,160
+22% +$366K
CSCO icon
39
Cisco
CSCO
$457B
$2.03M 0.79%
17,265
+8,600
+99% +$899K
FCX icon
40
Freeport-McMoran
FCX
$90B
$1.97M 0.77%
31,320
+14,195
+83% +$913K
ULTA icon
41
Ulta Beauty
ULTA
$22B
$1.94M 0.76%
+4,303
New +$2.18M
ABT icon
42
Abbott
ABT
$183B
$1.92M 0.75%
21,174
-700
-3% -$63.9K
MCD icon
43
McDonald's
MCD
$192B
$1.88M 0.73%
6,969
-750
-10% -$215K
C icon
44
Citigroup
C
$222B
$1.88M 0.73%
13,452
-1,775
-12% -$231K
NVDA icon
45
NVIDIA
NVDA
$4.86T
$1.87M 0.73%
9,327
+100
+1% +$20.6K
GE icon
46
GE Aerospace
GE
$374B
$1.85M 0.72%
4,961
-1,058
-18% -$331K
NTR icon
47
Nutrien
NTR
$33.2B
$1.83M 0.71%
29,050
+20,000
+221% +$1.4M
COP icon
48
ConocoPhillips
COP
$147B
$1.79M 0.69%
+17,175
New +$2.04M
HLT icon
49
Hilton Worldwide
HLT
$72.1B
$1.76M 0.68%
5,325
+1,725
+48% +$567K
PB icon
50
Prosperity Bancshares
PB
$8.97B
$1.71M 0.67%
23,475
-1,550
-6% -$108K
1
2
3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2026 Portfolio in Review

As of Q2 2026, New England Research & Management held 167 positions worth $257M, up 8.6% from $237M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

New England Research & Management's Q2 2026 filing shows 24 new, 41 increased, 51 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 4,303 shares worth $1.94M. The largest sale was Capital One, an estimated $4.77M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2026 buy was Ulta Beauty: 4,303 shares worth $1.94M.
  • New England Research & Management added most to AstraZeneca in Q2 2026, an estimated $2.37M increase.
  • New England Research & Management's biggest Q2 2026 reduction was Idexx Laboratories, cutting an estimated $1.82M.
  • New England Research & Management fully exited Capital One in Q2 2026, selling an estimated $4.77M.
  • New England Research & Management's ten largest holdings make up 33% of its $257M portfolio in Q2 2026.
  • New England Research & Management opened 24 new positions and closed 33 in Q2 2026.
  • New England Research & Management's portfolio value rose 8.6% quarter-over-quarter to $257M.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.